Why the study?
Does Angiotensin II induce MCP-1 gene expression in rat vascular smooth muscle cells?
Does Angiotensin II induce MCP-1 gene expression in rat vascular smooth muscle cells?
Answers are grounded in this paper and cite their sources.
Angiotensin II may promote atherogenesis by directly activating MCP-1 gene expression in vascular smooth muscle cells via reactive oxygen species and mitogen-activated protein kinase-dependent signaling mechanisms.
Monocyte infiltration into the vessel wall, a key initial step in the process of atherosclerosis, is mediated in part by monocyte chemoattractant protein-1 (MCP-1). Hypertension, particularly in the presence of an activated renin-angiotensin system, is a major risk factor for the development of atherosclerosis. To investigate a potential molecular basis for a link between hypertension and atherosclerosis, we studied the effects of angiotensin II (Ang II) on MCP-1 gene expression in rat aortic smooth muscle cells. Rat smooth muscle cells treated with Ang II exhibited a dose-dependent increase in MCP-1 mRNA accumulation that was prevented by the AT1 receptor antagonist losartan. Ang II also activated MCP-1 gene transcription. Inhibition of NADH/NADPH oxidase, which generates superoxide and H2O2, with diphenylene iodonium or apocynin decreased Ang II-induced MCP-1 mRNA accumulation. Induction of MCP-1 gene expression by Ang II was inhibited by catalase, suggesting a second messenger role for H2O2. The tyrosine kinase inhibitor genistein and the mitogen-activated protein kinase kinase inhibitor PD098059 inhibited Ang II-induced MCP-1 gene expression, consistent with a mitogen-activated protein kinase-dependent signaling mechanism. Ang II may thus promote atherogenesis by direct activation of MCP-1 gene expression in vascular smooth muscle cells.
No takes yet. Share an insight, caveat, or question.
Chen et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: